Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,560 papers from all fields of science
Search
Sign In
Create Free Account
Vaccines, Virosome
Known as:
Vaccines, Virosome [Chemical/Ingredient]
, Virosome Vaccines
Vaccines using VIROSOMES as the antigen delivery system that stimulates the desired immune response.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
In Blood
Process of secretion
Virosomes
agonists
Expand
Narrower (1)
Inflexal V
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Construction of a Macrophage-Targeting Bio-nanocapsule-Based Nanocarrier.
Hao Li
,
Masaharu Somiya
,
K. Tatematsu
,
S. Kuroda
Methods in molecular biology
2020
Corpus ID: 201275526
The construction protocol of bio-nanocapsule (BNC)-based nanocarriers, named GL-BNC and GL-virosome, for targeted drug delivery…
Expand
Review
2016
Review
2016
Liposomal adjuvants for human vaccines
C. Alving
,
Z. Beck
,
G. Matyas
,
M. Rao
Expert Opinion on Drug Delivery
2016
Corpus ID: 30639153
ABSTRACT Introduction: Liposomes are well-known as drug carriers, and are now critical components of two of six types of…
Expand
2016
2016
Novel delivery of Chlorin e6 using anti-EGFR antibody tagged virosomes for fluorescence diagnosis of oral cancer in a hamster cheek pouch model.
K. Low
,
R. Bhuvaneswari
,
P. Thong
,
R. Bunte
,
K. Soo
European Journal of Pharmaceutical Sciences
2016
Corpus ID: 22931043
2007
2007
Use of a dialyzable short-chain phospholipid for efficient preparation of virosome vaccines against Newcastle disease
A. Homhuan
,
S. Prakongpan
2007
Corpus ID: 95058
Virosomes can be regarded as liposomes carrying the spike proteins of enveloped virus on their surface. To further advance the…
Expand
2006
2006
Rate, intensity, and duration of local reactions to a virosome-adjuvanted vs. an aluminium-adsorbed hepatitis A vaccine in UK travellers.
P. Clarke
,
Phillip Adams
,
Rubén Ibáñez
,
C. Herzog
Travel Medicine and Infectious Disease
2006
Corpus ID: 6143472
2005
2005
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
L. Bungener
,
A. Huckriede
,
A. de Mare
,
J. De Vries-Idema
,
J. Wilschut
,
T. Daemen
Vaccine
2005
Corpus ID: 260627602
Highly Cited
2004
Highly Cited
2004
Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children
G. Kanra
,
P. Marchisio
,
+6 authors
N. Principi
The Pediatric Infectious Disease Journal
2004
Corpus ID: 45698035
Objective. To compare the immunogenicity and safety of a virosome-adjuvanted influenza vaccine (Inflexal V; Berna Biotech, Berne…
Expand
1995
1995
Characteristics of Cytotoxic T Lymphocytes Directed to Influenza Virus Haemagglutinin Elicited by Immunization with Muramyldipeptide‐Influenza Liposome Vaccine
H. Hnuma
,
K. Nerome
,
Y. Yoshioka
,
K. Okinaga
Scandinavian Journal of Immunology
1995
Corpus ID: 11045411
We examined the characterization of the antiviral T lymphocytes elicited by immunization with a novel liposome vaccine (MDP…
Expand
1993
1993
Reconstituted Sendai virus envelopes as biological carriers: dual role of F protein in binding and fusion with liver cells.
Sangeeta Bagai
,
D. P. Sarkar
Biochimica et Biophysica Acta
1993
Corpus ID: 12416008
1992
1992
Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).
M. Kaji
,
Y. Kaji
,
+7 authors
M. Sentoku
Vaccine
1992
Corpus ID: 36617994
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required